Risk of Cytomegalovirus Reactivation in Patients With Immune-Mediated Inflammatory Diseases Undergoing Biologic Treatment: A Real Matter?
Reumatismo - Italy
doi 10.4081/reumatismo.2016.897
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 16, 2016
Authors
Publisher
PAGEPress Publications